DE103553T1 - Zwischenverbindungen fuer die herstellung von omeprazol. - Google Patents
Zwischenverbindungen fuer die herstellung von omeprazol.Info
- Publication number
- DE103553T1 DE103553T1 DE198383850185T DE83850185T DE103553T1 DE 103553 T1 DE103553 T1 DE 103553T1 DE 198383850185 T DE198383850185 T DE 198383850185T DE 83850185 T DE83850185 T DE 83850185T DE 103553 T1 DE103553 T1 DE 103553T1
- Authority
- DE
- Germany
- Prior art keywords
- compound
- formula
- compound according
- preparation
- omeprazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/68—One oxygen atom attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Compounds Of Unknown Constitution (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Claims (1)
1 83 850 185.6 Aktiebolaget Hässle
Patenansprüche
1. Verbindung der Formel
OCH.
worin R H oder CH~ ist.
2. Verbindung nach Anspruch 1 der Formel
CH,
3. Verbindung nach Anspruch 1 der Formel
OCH-
4. Verbindung nach den Ansprüchen 1 bis 3 in Form einer Masse
15. Verfahren zur Herstellung einer Verbindung der Formel
OCH
CH.
worin R H oder CH ist, dadurch gekennzeichnet, daß
a) eine Verbindung der Formel
mit einem Nitriermittel, wie
NHO.
III
unter Bildung einer Verbindung der Formel
IV
umgesetzt wird, wobei in diesen Formeln R H oder CH. bedeutet, wonach
b) die so erhaltene Verbindung der Formel IV direkt mit Alkali unter Bildung einer Verbindung der Formel
worin R H oder CH, ist,
10
10
umgesetzt wird.
6. Verwendung einer Verbindung nach den Ansprüchen 1 bis 4 als ein Zwischenprodukt bei der Herstellung pharmazeu-tisch
verwendbarer Verbindungen.
7. Verwendung einer Verbindung nach den Ansprüchen 1 bis 4 als ein Zwischenprodukt bei der Herstellung substituierter
Benzimidazole, die einen Pyridinrest enthalten.
8. Verwendung einer Verbindung nach den Ansprüchen 1 bis 4 als ein Zwischenprodukt bei der Herstellung von Omeprazol.
9. Verbindungen, Verfahren zu ihrer Herstellung und ihrer Verwendung, wie in den Ansprüchen 1 bis 8 beansprucht
und im wesentlichen wie beschrieben.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8204879A SE8204879D0 (sv) | 1982-08-26 | 1982-08-26 | Novel chemical intermediates |
Publications (1)
Publication Number | Publication Date |
---|---|
DE103553T1 true DE103553T1 (de) | 1984-09-27 |
Family
ID=20347627
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE198383850185T Pending DE103553T1 (de) | 1982-08-26 | 1983-06-30 | Zwischenverbindungen fuer die herstellung von omeprazol. |
DE8383850185T Expired DE3379222D1 (en) | 1982-08-26 | 1983-06-30 | Intermediates for the preparation of omeprazole |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE8383850185T Expired DE3379222D1 (en) | 1982-08-26 | 1983-06-30 | Intermediates for the preparation of omeprazole |
Country Status (28)
Country | Link |
---|---|
US (2) | US4544750A (de) |
EP (1) | EP0103553B1 (de) |
JP (1) | JPS5959662A (de) |
KR (1) | KR880000091B1 (de) |
AT (1) | ATE40884T1 (de) |
AU (1) | AU560028B2 (de) |
CA (1) | CA1234118A (de) |
CY (1) | CY1328A (de) |
DD (1) | DD233126A5 (de) |
DE (2) | DE103553T1 (de) |
DK (1) | DK381583A (de) |
ES (1) | ES525122A0 (de) |
FI (1) | FI79701C (de) |
GB (1) | GB2126226B (de) |
GR (1) | GR79374B (de) |
HK (1) | HK19486A (de) |
HU (1) | HU189738B (de) |
IE (1) | IE55865B1 (de) |
IL (1) | IL69175A (de) |
IS (1) | IS1438B6 (de) |
MY (1) | MY8600503A (de) |
NO (1) | NO164093C (de) |
NZ (1) | NZ204959A (de) |
OA (1) | OA07498A (de) |
PH (1) | PH17786A (de) |
PT (1) | PT77249B (de) |
SE (1) | SE8204879D0 (de) |
ZA (1) | ZA835143B (de) |
Families Citing this family (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8404065D0 (sv) * | 1984-08-10 | 1984-08-10 | Haessle Ab | Novel biologically active compounds |
SE8504409D0 (sv) * | 1985-09-24 | 1985-09-24 | Haessle Ab | Novel chemical intermediates |
ES2053533T3 (es) * | 1986-04-17 | 1994-08-01 | Ici Plc | Derivados de esteres de acido piridil-acrilico, un proceso para su preparacion y su uso como fungicidas. |
US5221316A (en) * | 1986-04-17 | 1993-06-22 | Imperial Chemical Industries Plc | Fungicides |
US4920230A (en) * | 1987-06-29 | 1990-04-24 | Takeda Chemical Industries, Ltd. | Method of producing nitrogen-containing heteroaromatic compounds having an alkoxy group |
AT391693B (de) * | 1988-11-15 | 1990-11-12 | Cl Pharma | Verfahren zur herstellung von 3-5-dimethyl-4methoxypyridinderivaten sowie neues zwischenprodukt hierfuer |
US4965269A (en) * | 1989-12-20 | 1990-10-23 | Ab Hassle | Therapeutically active chloro substituted benzimidazoles |
ES2026761A6 (es) * | 1990-10-31 | 1992-05-01 | Genesis Para La Investigacion | Procedimiento de obtencion del omeprazol. |
ES2036948B1 (es) * | 1991-11-21 | 1994-09-01 | Genesis Para La Investigacion | Procedimiento de obtencion de compuestos derivados de piridina. |
ES2060541B1 (es) * | 1993-02-26 | 1995-11-16 | Vinas Lab | Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo. |
SE9301830D0 (sv) * | 1993-05-28 | 1993-05-28 | Ab Astra | New compounds |
ES2097089B1 (es) * | 1995-02-01 | 1997-12-16 | Esteve Quimica Sa | Procedimiento para la preparacion de 2-hidroximetil-3,5-dimetil-4-metoxipiridina. |
US6645988B2 (en) | 1996-01-04 | 2003-11-11 | Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
US6699885B2 (en) | 1996-01-04 | 2004-03-02 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and methods of using same |
US5840737A (en) | 1996-01-04 | 1998-11-24 | The Curators Of The University Of Missouri | Omeprazole solution and method for using same |
US6489346B1 (en) | 1996-01-04 | 2002-12-03 | The Curators Of The University Of Missouri | Substituted benzimidazole dosage forms and method of using same |
WO1999033807A2 (en) * | 1997-12-24 | 1999-07-08 | Pdi-Research Laboratories, Inc. | Synthesis of pharmaceutically useful pyridine derivatives (intermediates) employing free radical substitution reactions to functionalize the 2-position of the pyridine |
CA2204580A1 (en) * | 1997-05-06 | 1998-11-06 | Michel Zoghbi | Synthesis of pharmaceutically useful pyridine derivatives |
US6437139B1 (en) | 1997-05-06 | 2002-08-20 | Pdi-Research Laboratories, Inc. | Synthesis of pharmaceutically useful pyridine derivatives |
GB9717849D0 (en) * | 1997-08-23 | 1997-10-29 | Seal Sands Chemicals Limited | Preparation of pyridene derivatives |
US6096340A (en) * | 1997-11-14 | 2000-08-01 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6174548B1 (en) | 1998-08-28 | 2001-01-16 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
KR100396431B1 (ko) * | 1998-01-26 | 2003-09-02 | 가부시키가이샤 구라레 | 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이 |
US6350876B2 (en) | 1998-01-26 | 2002-02-26 | Kuraray Co., Ltd. | 4-chloro-3,5-dimethyl-2-sulfonyl pyridines |
US6303787B1 (en) | 1998-05-27 | 2001-10-16 | Natco Pharma Limited | Intermediates and an improved process for the preparation of Omeprazole employing the said intermediates |
IE990506A1 (en) * | 1998-06-26 | 2000-11-15 | Russinsky Ltd | Pyridine Building Blocks |
US6733778B1 (en) | 1999-08-27 | 2004-05-11 | Andrx Pharmaceuticals, Inc. | Omeprazole formulation |
US6353005B1 (en) | 1999-03-02 | 2002-03-05 | Sepracor, Inc. | Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist |
US6362202B1 (en) | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
US6555139B2 (en) | 1999-06-28 | 2003-04-29 | Wockhardt Europe Limited | Preparation of micron-size pharmaceutical particles by microfluidization |
US6245913B1 (en) | 1999-06-30 | 2001-06-12 | Wockhardt Europe Limited | Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole |
US6780880B1 (en) | 1999-08-26 | 2004-08-24 | Robert R. Whittle | FT-Raman spectroscopic measurement |
US6312723B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6268385B1 (en) | 1999-08-26 | 2001-07-31 | Robert R. Whittle | Dry blend pharmaceutical formulations |
US6316020B1 (en) | 1999-08-26 | 2001-11-13 | Robert R. Whittle | Pharmaceutical formulations |
US6262085B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
US6326384B1 (en) | 1999-08-26 | 2001-12-04 | Robert R. Whittle | Dry blend pharmaceutical unit dosage form |
US6312712B1 (en) | 1999-08-26 | 2001-11-06 | Robert R. Whittle | Method of improving bioavailability |
US6262086B1 (en) | 1999-08-26 | 2001-07-17 | Robert R. Whittle | Pharmaceutical unit dosage form |
US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
GB9921578D0 (en) * | 1999-09-13 | 1999-11-17 | Cipla Limited | Omeprazole synthesis |
ES2171116B1 (es) * | 2000-04-14 | 2003-08-01 | Esteve Quimica Sa | Procedimiento para la obtencion de derivados de (((piridil sustituido)metil)tio)bencimidazol. |
WO2003097606A1 (en) * | 2000-07-28 | 2003-11-27 | Herbex, Produtos Químicos, Sa | New method for the preparation of the anti-ulcer compounds omeprazole, lansoprazole and pantoprazole |
PT1387842E (pt) | 2001-05-11 | 2009-07-20 | Tibotec Pharm Ltd | 2-aminobenzoxazolsulfonamidas inibidoras de largo espectro da protease hiv |
CA2472103A1 (en) * | 2002-01-25 | 2003-08-07 | Santarus, Inc. | Transmucosal delivery of proton pump inhibitors |
FR2848555B1 (fr) | 2002-12-16 | 2006-07-28 | Negma Gild | Enantiomere(-)du tenatoprazole et son application en therapeutique |
US8993599B2 (en) | 2003-07-18 | 2015-03-31 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
US8906940B2 (en) | 2004-05-25 | 2014-12-09 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
CN100376574C (zh) * | 2006-06-14 | 2008-03-26 | 浙江大学 | 泰妥拉唑的制备方法 |
EA200900985A1 (ru) | 2007-01-31 | 2009-12-30 | Крка, Товарна Здравил, Д. Д., Ново Место | Способ получения оптически чистого омепразола |
CN101648912B (zh) * | 2009-09-14 | 2012-07-04 | 南京第一农药集团有限公司 | 一种4-硝基-3,5-二甲基吡啶-n-氧化物的连续化制备方法 |
CN101648907B (zh) * | 2009-09-14 | 2011-08-03 | 南京第一农药集团有限公司 | 2-氯甲基-4-甲氧基-3,5-二甲基吡啶盐酸盐的纯化方法 |
CN102603620B (zh) * | 2012-01-13 | 2014-10-29 | 江苏中邦制药有限公司 | 一种氯甲基吡啶或其吡啶衍生物盐酸盐的合成方法 |
TW202126317A (zh) | 2019-09-24 | 2021-07-16 | 美商普拉塔生技公司 | 用於治療發炎和免疫疾病之組成物和方法 |
CN112142653B (zh) * | 2020-10-22 | 2022-02-11 | 成都百泉生物医药科技有限公司 | 奥美拉唑中间体的制备方法 |
CN113307773A (zh) * | 2021-06-17 | 2021-08-27 | 上海毕得医药科技股份有限公司 | 6-溴-3-甲氧基-1-苯基-1h-吲唑及其合成方法和应用 |
CN114805193B (zh) * | 2022-04-19 | 2023-06-20 | 南京红太阳医药研究院有限公司 | 一种奥美拉唑中间体的制备方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2735851A (en) * | 1956-02-21 | Alkanolpykroine-n-oxides | ||
US2663711A (en) * | 1951-12-08 | 1953-12-22 | Du Pont | Process for the preparation of pyridine alcohols from pyridine n-oxides |
GB1564502A (en) * | 1975-07-31 | 1980-04-10 | Smith Kline French Lab | Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives |
SE7804231L (sv) * | 1978-04-14 | 1979-10-15 | Haessle Ab | Magsyrasekretionsmedel |
US4472409A (en) * | 1981-11-05 | 1984-09-18 | Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung | 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects |
JPS58135881A (ja) * | 1981-11-05 | 1983-08-12 | ビク−グルデン・ロムベルク・ヘミツシエ・フアブリク・ゲゼルシヤフト・ミト・ベシユレンクテル・ハフツング | 置換ベンズイミダゾ−ル類、その製造方法と利用、およびこれを含む医薬 |
-
1982
- 1982-08-26 SE SE8204879A patent/SE8204879D0/xx unknown
-
1983
- 1983-06-30 DE DE198383850185T patent/DE103553T1/de active Pending
- 1983-06-30 DE DE8383850185T patent/DE3379222D1/de not_active Expired
- 1983-06-30 AT AT83850185T patent/ATE40884T1/de not_active IP Right Cessation
- 1983-06-30 EP EP83850185A patent/EP0103553B1/de not_active Expired
- 1983-07-06 IL IL69175A patent/IL69175A/xx not_active IP Right Cessation
- 1983-07-06 CA CA000431863A patent/CA1234118A/en not_active Expired
- 1983-07-14 ZA ZA835143A patent/ZA835143B/xx unknown
- 1983-07-20 OA OA58065A patent/OA07498A/xx unknown
- 1983-07-20 NZ NZ204959A patent/NZ204959A/en unknown
- 1983-07-20 AU AU17101/83A patent/AU560028B2/en not_active Expired
- 1983-07-28 IE IE1787/83A patent/IE55865B1/en not_active IP Right Cessation
- 1983-08-02 NO NO832794A patent/NO164093C/no not_active IP Right Cessation
- 1983-08-08 PH PH29368A patent/PH17786A/en unknown
- 1983-08-18 DD DD83254056A patent/DD233126A5/de unknown
- 1983-08-19 DK DK381583A patent/DK381583A/da not_active Application Discontinuation
- 1983-08-24 ES ES525122A patent/ES525122A0/es active Granted
- 1983-08-25 PT PT77249A patent/PT77249B/pt unknown
- 1983-08-25 CY CY1328A patent/CY1328A/xx unknown
- 1983-08-25 JP JP58154250A patent/JPS5959662A/ja active Granted
- 1983-08-25 FI FI833047A patent/FI79701C/fi not_active IP Right Cessation
- 1983-08-25 HU HU832987A patent/HU189738B/hu unknown
- 1983-08-25 GB GB08322866A patent/GB2126226B/en not_active Expired
- 1983-08-26 GR GR72304A patent/GR79374B/el unknown
- 1983-08-26 KR KR1019830004003A patent/KR880000091B1/ko not_active IP Right Cessation
- 1983-08-26 US US06/526,900 patent/US4544750A/en not_active Expired - Lifetime
- 1983-08-26 IS IS2845A patent/IS1438B6/is unknown
-
1985
- 1985-02-01 US US06/697,396 patent/US4620008A/en not_active Expired - Lifetime
-
1986
- 1986-03-20 HK HK194/86A patent/HK19486A/xx not_active IP Right Cessation
- 1986-12-30 MY MY503/86A patent/MY8600503A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE103553T1 (de) | Zwischenverbindungen fuer die herstellung von omeprazol. | |
EP0173172A3 (de) | Neue 3-Pyridylverbindungen und Verfahren zu ihrer Herstellung | |
EP0237963A3 (de) | 2-Azolylmethyl-2-aryl-1,3-dioxolane und deren Salze, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung | |
DE647229T1 (de) | Diaminsalze von clavulansäure. | |
DE2748920C2 (de) | 3-Fluor-6-piperazino-morphanthridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate | |
EP0315009A3 (de) | Chromanderivate, Verfahren zu ihrer Herstelllung und ihre Verwendung in Arzneimitteln | |
EP0166331A3 (de) | Substituierte Phenoxyalkylaminopropanole, Verfahren zu ihrer Herstellung und ihre Verwendung sowie diese Verbindungen enthaltende Zubereitungen | |
EP0089597A3 (de) | Sulfonylharnstoffe, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung | |
EP0279201A3 (de) | Verfahren zur Herstellung von 2-Cyano-2-oximino-acetamid-Derivaten | |
DE1211156B (de) | Verfahren zur Herstellung von ungesaettigten Sulfonsaeurebetainen durch Umsetzen eines tertiaeren Amins mit einem Sulton | |
DE91652T1 (de) | Ergolinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
EP0133670A3 (de) | Verfahren zur Herstellung von 7-Acylamino-3-hydrocy-cephem-4-carbonsäuren und 7-Acylamino-3-hydroxy-1-de-thia-1-oxacephem-4-carbonsäuren | |
DE2660902C2 (de) | Dicarbonsäure-bis[3,5-bis(chlorcarbonyl)-2,4,6-trijodanilid]- Verbindungen und deren Herstellung | |
DE3378980D1 (en) | Benzazepine derivatives, process for their preparation and their use as pharmaceutical compounds | |
EP0271780A3 (de) | Substituierte 1-Benzylsulfonyl-3-heteroaryl-(thio)harnstoffe | |
DE942027C (de) | Verfahren zur Herstellung von substituierten 2-Iminothiazolidinen | |
DE2534811A1 (de) | Verfahren zur herstellung von cephalosporinen | |
DE3426644A1 (de) | N,n-bis((1-aryl-3-methyltriazen-3-yl) methyl)ether | |
DE679711C (de) | Verfahren zur Herstellung von AEthersaeuren | |
DE869490C (de) | Verfahren zur Herstellung von fluoreszierenden heterocyclischen Verbindungen | |
EP0237918A3 (de) | N-Substituierte Aminoalkansäuren, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen | |
DE2417254C3 (de) | Flüssige Farbstoffzubereitungen eines Reaktivfarbstoffes | |
EP0144847A3 (de) | Hydroxy-tetrahydropyridinlactone, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln | |
DE3741946A1 (de) | Polysilan | |
DE1644270A1 (de) | Verfahren zur Herstellung von Azofarbstoffen |